References
- Azziz R, Woods K S, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism 2004; 89: 2745–2749
- Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997; 18: 774–800
- Nagmani M, Lingold J C, Gomez L G, et al. Clinical and hormonal studies in hyperthecosis of the ovaries. Fertility and Sterility 1982; 36: 326–332
- Steingold K A, Howard L J, Nieberg R K, et al. Treatment of severe androgen excess due to ovarian hyperthecosis with long gonadotropins-releasing hormone agonist. American Journal of Obstetrics and Gynecology 1986; 154: 1241–1248
- The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome. Fertility and Sterility 2004; 81: 19–25